Recombinant multi-species ADAMTS18 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ADAMTS18 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. ADAMTS family members share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protein, which may regulate hemostatic balance and function as a tumor suppressor. Mutations in this gene may be associated with microcornea, myopic chorioretinal atrophy, and telecanthus (MMCAT) and cone-rod dystrophy in human patients. [provided by RefSeq, May 2016]
The Alternative Names of target: 9630038L21,A disintegrin and metalloproteinase with thrombospondin motifs 18,ADAM-TS 18,ADAM-TS18,ADAMTS-18,ADAMTS18,ADAMTS21,Adamts18,E130314N14Rik,KNO2,MMCAT,RGD1560118

Target products collectionGo to ADAMTS18 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0643-Ag-1/ GM-Tg-hg-SE0643-Ag-2 Human ADAMTS18 protein Human
GM-Tg-rg-SE0643-Ag-1/ GM-Tg-rg-SE0643-Ag-2 Rat ADAMTS18 protein Rat
GM-Tg-mg-SE0643-Ag-1/ GM-Tg-mg-SE0643-Ag-2 Mouse ADAMTS18 protein Mouse
GM-Tg-cynog-SE0643-Ag-1/ GM-Tg-cynog-SE0643-Ag-2 Cynomolgus/Rhesus macaque ADAMTS18 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0643-Ag-1/ GM-Tg-felg-SE0643-Ag-2 Feline ADAMTS18 protein Feline
GM-Tg-cang-SE0643-Ag-1/ GM-Tg-cang-SE0643-Ag-2 Canine ADAMTS18 protein Canine
GM-Tg-bovg-SE0643-Ag-1/ GM-Tg-bovg-SE0643-Ag-2 Bovine ADAMTS18 protein Bovine
GM-Tg-equg-SE0643-Ag-1/ GM-Tg-equg-SE0643-Ag-2 Equine ADAMTS18 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0643-Ag-1/ GM-Tg-hg-SE0643-Ag-2; GM-Tg-rg-SE0643-Ag-1/ GM-Tg-rg-SE0643-Ag-2;
GM-Tg-mg-SE0643-Ag-1/ GM-Tg-mg-SE0643-Ag-2; GM-Tg-cynog-SE0643-Ag-1/ GM-Tg-cynog-SE0643-Ag-2;
GM-Tg-felg-SE0643-Ag-1/ GM-Tg-felg-SE0643-Ag-2; GM-Tg-cang-SE0643-Ag-1/ GM-Tg-cang-SE0643-Ag-2;
GM-Tg-bovg-SE0643-Ag-1/ GM-Tg-bovg-SE0643-Ag-2; GM-Tg-equg-SE0643-Ag-1/ GM-Tg-equg-SE0643-Ag-2
Products Name ADAMTS18 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ADAMTS18
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ADAMTS18 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.